Duopharma Biotech Bhd will soon distribute a range of IRORO brand halal-certified anti-hair loss products in Malaysia.
Its wholly-owned subsidiary Duopharma Consumer Healthcare Sdn Bhd, recently signed a Product Distribution Agreement with South Korea-based stem cell technology company SCM Lifescience, Inc. IRORO is using stem cell technology as its active ingredient to create a halal range catering to the Malaysian market.
The product range to be distributed by Duopharma Consumer Healthcare comprises:
- IRORO Nutreatment Anti-Hair Loss Shampoo for Men
- IRORO Nutreatment Anti-Hair Loss Shampoo for Women
- IRORO Nutreatment Anti-Hair Loss Treatment
- IRORO Nutreatment Anti-Hair Loss Serum
“This agreement with SCM Lifescience enables Duopharma Consumer Healthcare to expand our entry into the cosmeceutical segment with the halal-certified IRORO range specially formulated for Malaysia.
“Following Duopharma Biotech’s 2.73 per cent investment into SCM Lifescience, we are committed to optimising their findings – particularly in stem cell research, to elevate our consumer product offerings, enabling us to have a unique advantage in the market,” said Duopharma Biotech Group Managing Director Leonard Ariff Abdul Shatar.
“We are also collaborating with SCM Lifescience to develop atopic dermatitis stem cell therapy. By introducing the IRORO range, we are laying the groundwork for this product segment ahead of a potential launch of products to treat atopic dermatitis.”
The stem cell used in IRORO will be able to promote hair growth as well as scalp improvement. The researchers found that after two weeks of use, research participants experienced an increase in scalp pore cleanliness and skin moisture levels, without any
skin irritation observed, findings which were verified by a nationally-certified clinical institution in South Korea.
“We are pleased to collaborate with Duopharma Consumer Healthcare in bringing the IRORO brand to Malaysia. Hair loss can have various factors including genetics, diet and environmental factors that can differ across markets, but we are confident in the efficacy of the IRORO range and excited to see the brand helping Malaysians overcome the impact of hair loss.
“We foresee that this product range will be the first among other products made available to Malaysians through our R&D collaboration with Duopharma Consumer Healthcare,” said SCM Lifescience CEO Dr Byong Kwan Son.
The IRORO product range will be available to consumers through e-commerce platforms in Malaysia in the first quarter of 2023.